StockData
ADARx Pharmaceuticals, Inc. logo

ADARx Pharmaceuticals, Inc. (ADRX) stock

ADRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026
$14.20−0.71 (-4.76%)

Close on Nov 13, 2026Market cap $1.52BP/E –Yield –

ADARx Pharmaceuticals statistics

30 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
–
Last ex-dividend date
No dividends
Fundamentals through
Sep 30, 2026
Share price as of
Nov 13, 2026

Valuation ratiosIndustry

Market Cap
$1.52B
$272.32M
Enterprise Value
$622.03M
$146.23M
PB Ratio
2.65
2.00
P/TBV Ratio
2.65
2.22

Share statisticsIndustry

Float
55M
49M
Shares Held by Insiders
48.7%
11.7%

Short sellingIndustry

Short Interest
2M
–
Short Interest Change
-5.37%
-0.80%
Short % of Float
3.27%
9.01%
Short % of Shares Outstanding
1.68%
6.30%
Days to Cover
5.02
5.15

Stock price statisticsIndustry

20-Day Moving Average
$15.98
–
Average True Range (14)
$1.63
–
Price Change (1 Week)
7.33%
-1.15%
Price Change (1 Month)
-19.8%
-4.87%
Average Volume (10 Days)
509,591
–
Average Volume (20 Days)
441,784
–
Average Volume (90 Days)
649,811
–
Relative Volume
0.90
0.70

Financial positionIndustry

Current Ratio
21.08
3.30
Quick Ratio
20.68
2.39

Balance sheetIndustry

Net Cash (Debt)
$901.01M
$17.76M
Net Cash Per Share
$8.40
$0.80
Equity (Book Value)
$574.40M
$53.89M
Book Value Per Share
$5.36
$1.50
Tangible Book Value
$574.40M
$27.13M
Working Capital
$874.94M
$79.99M

Scores and fair valueIndustry

Altman Z-Score
3.26
0.23

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.

PeriodADRXS&P 500DifferenceADRX per yearS&P 500 per year
1 month-19.8%-3.0%−16.7 pts

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

2M ADRX shares were sold short on Oct 30, 2026, down 5.4% from the previous report, or 3.27% of the shares available to trade. At recent volumes it would take 5.0 days to buy them back. Over the last 20 sessions, 57.7% of the volume reported to FINRA was short selling.

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 30, 20261,801,373-5.4%358,5455.0
Oct 15, 20261,903,521+63.6%611,7103.1
Sep 30, 20261,163,375–669,7711.7

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?